Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2003
09/18/2003US20030175850 Devices and methods for isolating target cells
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175823 Method of screening remedy for heart failures
09/18/2003US20030175807 Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175791 Comprises enzymatic peptide for treating cancer, psoriasis, arteriosclerosis and inflammation
09/18/2003US20030175790 High throughput screening for detecting modulators of molecular interaction and cellular processes
09/18/2003US20030175767 Chemoreceptors in plant parasitic nematodes
09/18/2003US20030175758 FabK variant
09/18/2003US20030175757 Comprises enzymatic polypeptide associated with fatty acid biosynthesis (FABK) for diagnosing streptococcus infections; bactericides
09/18/2003US20030175756 Thermus igniterrae nucleic acid polymerases
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175738 Rna polymerase mutants with increased thermostability
09/18/2003US20030175735 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity
09/18/2003US20030175700 Comprises nucleotide sequences coding chlamydia antigen for serodiagnosis and traetment of infection; genetic vaccines
09/18/2003US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections
09/18/2003US20030175679 Detecting modulators of ubiquitin conjugating enzyme complex formation; drug screening
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175309 Adjuvants for use in vaccines
09/18/2003US20030175308 Adjuvants for use in vaccines
09/18/2003US20030175299 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections; stable oil-in-water emulsions, side effect reduction
09/18/2003US20030175298 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections
09/18/2003US20030175297 Cancer vaccines
09/18/2003US20030175296 Chimaeric hepadnavirus core antigen proteins
09/18/2003US20030175294 Heterologous fusion protein constructs comprising a Leishmania antigen
09/18/2003US20030175293 Choline binding proteins for anti-pneumococcal vaccines
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175288 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175265 Chandra: a novel Th1-specific gene
09/18/2003US20030175258 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003US20030172698 Organic nitrogen-containing composition and fertilizer comprising the same
09/18/2003US20030172588 Sulfur-oxidizing plant growth promoting rhizobacteria for enhanced canola performance
09/18/2003CA2485142A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
09/18/2003CA2478904A1 Modified gene-silencing rna and uses thereof
09/18/2003CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003CA2478510A1 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003CA2478169A1 Human antibodies specific to kdr and uses thereof
09/18/2003CA2478120A1 Contrast agents containing ferritin for magnetic resonance imaging and methods related thereto
09/18/2003CA2477975A1 Novel vip3 toxins and methods of use
09/18/2003CA2477273A1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
09/17/2003EP1344827A2 Antifreeze proteins from basidiomycetes
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
09/17/2003EP1344821A1 Novel aggrecanase
09/17/2003EP1344820A1 Zygomycetes-origin endoglucanase lacking cellulose-binding domain
09/17/2003EP1344458A1 Probiotic delivery system
09/17/2003EP1344064A2 Compositions and methods relating to prostate specific genes and proteins
09/17/2003EP1343903A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
09/17/2003EP1343902A2 Recombinant porcine liver esterases, their use and a method for the production thereof
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343898A1 Novel thermostable galactose isomerase and tagatose production thereby
09/17/2003EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments
09/17/2003EP1343891A2 Colon cancer marker
09/17/2003EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/17/2003EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/17/2003EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer
09/17/2003EP1343884A2 Jfy1 protein induces rapid apoptosis
09/17/2003EP1343883A2 Aspergillus fumigatus cofilin
09/17/2003EP1343881A2 Method for generating competent or transformed cells
09/17/2003EP1343875A2 Sugar beet genes involved in stress tolerance
09/17/2003EP1343874A2 3-hydroxypropionic acid and other organic compounds
09/17/2003EP1343870A2 Bacterial expression systems
09/17/2003EP1343822A2 Means for the diagnosis and therapy of ctcl
09/17/2003EP1343818A1 Modified tachykinin receptors
09/17/2003EP1343815A2 Antibacterial treatments
09/17/2003EP1343813A1 Novel compounds
09/17/2003EP1343812A1 Protein cluster ii
09/17/2003EP1343729A1 Microbiological composition
09/17/2003EP1343525A2 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE
09/17/2003EP1343377A2 Preventing corrosion with beneficial biofilms
09/17/2003EP1343370A2 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
09/17/2003EP1343369A1 Preservation of cells
09/17/2003EP1124941B1 Process for recovering heterologous polypeptides from bacterial cells
09/17/2003EP0981627B1 Purified telomerase
09/17/2003EP0938581B1 Apparatus and method for the continuous conversion of a cellulosic material to ethanol
09/17/2003EP0840784B1 Method of producing and purifying enzymes
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003EP0478664B1 Vector-mediated genomic insertion and expression of dna in bcg
09/17/2003CN1443242A Modified construct downstream of initiation codon for recombinant protein over expression
09/17/2003CN1443240A Interferon-like protein zcyto 21
09/17/2003CN1443239A Compositions and methods for therapy and diagnosis of breast cancer
09/17/2003CN1443236A Novel amylolytic enzyme extracted from bacillus SP.A7-7(DSM 12368)and washing and cleaning agents containing this novel amylolytic enzyme
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/17/2003CN1442477A Solid fermentation process of streptomyces flavus and its production equipment
09/17/2003CN1442476A Liquid fermentation process of streptomyces flavus and its production equipment
09/17/2003CN1442394A Biological high nitrogen source fermentation technology
09/17/2003CN1442151A Mackefulan immune liquid
09/17/2003CN1121500C Method for production of dicarboxylic acids
09/17/2003CN1121499C Process for producing moroctic acid by induction
09/17/2003CN1121498C Hay bacillus expression element of giant bacillus penicillin G amidase
09/17/2003CN1121497C D-pantolactone hydrolase and gene encoding the same
09/17/2003CN1121495C Microbe and method of producing biological mematocide with microbe
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620610 For the preparation of transgenic crop plants, such as tobacco, potatoes, beets and maize with increased yield, by altering their nitrogen metabolism
09/16/2003US6620609 Process of microwave sterilization of culture media for selection of recombinant microorganisms
1 ... 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 ... 1489